239 related articles for article (PubMed ID: 29442287)
1. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
Orellana-Noia VM; Douvas MG
Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287
[TBL] [Abstract][Full Text] [Related]
2. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
Yamazaki E
Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
[TBL] [Abstract][Full Text] [Related]
3. [Acute lymphoblastic leukemia in adolescents and young adults].
Hayakawa F
Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
[TBL] [Abstract][Full Text] [Related]
4. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
Curran E; Stock W
Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
[TBL] [Abstract][Full Text] [Related]
5. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
[No Abstract] [Full Text] [Related]
6. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in adolescents and young adults.
Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM
Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia in adolescents and young adults.
Ribera JM; Oriol A
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1033-42, vi. PubMed ID: 19825451
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
McNeer JL; Bleyer A
Pediatr Blood Cancer; 2018 Jun; 65(6):e26989. PubMed ID: 29418064
[TBL] [Abstract][Full Text] [Related]
10. Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults.
Friend BD; Schiller GJ
Blood Rev; 2018 Mar; 32(2):122-129. PubMed ID: 28969872
[TBL] [Abstract][Full Text] [Related]
11. [Acute lymphoblastic leukemia in adolescents and young adults: from the viewpoint of pediatricians].
Koh K
Rinsho Ketsueki; 2017; 58(8):1024-1030. PubMed ID: 28883265
[TBL] [Abstract][Full Text] [Related]
12. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
[TBL] [Abstract][Full Text] [Related]
13. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
Advani AS; Hanna R
Leuk Lymphoma; 2020 Jan; 61(1):18-26. PubMed ID: 31452423
[TBL] [Abstract][Full Text] [Related]
14. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
[TBL] [Abstract][Full Text] [Related]
15. Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai population.
Limvorapitak W; Owattanapanich W; Utchariyaprasit E; Niparuck P; Puavilai T; Tantiworawit A; Rattanathammethee T; Saengboon S; Sriswasdi C; Julamanee J; Saelue P; Polprasert C; Wudhikarn K; Wanitpongpun C; Prayongratana K;
Leuk Res; 2019 Dec; 87():106235. PubMed ID: 31675661
[TBL] [Abstract][Full Text] [Related]
16. New developments in ALL in AYA.
Boissel N
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):190-196. PubMed ID: 36485092
[TBL] [Abstract][Full Text] [Related]
17. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
[TBL] [Abstract][Full Text] [Related]
18. How should we treat the AYA patient with newly diagnosed ALL?
Boissel N
Best Pract Res Clin Haematol; 2017 Sep; 30(3):175-183. PubMed ID: 29050690
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
